Switch theme
Sign up to access all valuation multiples
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices, and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
2013
1.1K+
LTM Revenue $369M
LTM EBITDA $45.8M
$238M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sisram Medical has a last 12-month revenue of $369M and a last 12-month EBITDA of $45.8M.
In the most recent fiscal year, Sisram Medical achieved revenue of $46.2M and an EBITDA of $6.9M.
Sisram Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sisram Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $45.6M | $46.2M | XXX | XXX | XXX |
| Gross Profit | $21.5M | $26.0M | XXX | XXX | XXX |
| Gross Margin | 47% | 56% | XXX | XXX | XXX |
| EBITDA | $7.5M | $6.9M | XXX | XXX | XXX |
| EBITDA Margin | 17% | 15% | XXX | XXX | XXX |
| Net Profit | $4.0M | $5.2M | XXX | XXX | XXX |
| Net Margin | 9% | 11% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Sisram Medical's stock price is HKD 4 (or $1).
Sisram Medical has current market cap of HKD 2.1B (or $267M), and EV of HKD 1.9B (or $238M).
See Sisram Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $238M | $267M | XXX | XXX | XXX | XXX | $0.06 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Sisram Medical has market cap of $267M and EV of $238M.
Sisram Medical's trades at 0.6x LTM EV/Revenue multiple, and 5.2x LTM EBITDA.
Analysts estimate Sisram Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Sisram Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $238M | XXX | XXX | XXX |
| EV/Revenue | 5.2x | XXX | XXX | XXX |
| EV/EBITDA | 34.7x | XXX | XXX | XXX |
| P/E | 65.9x | XXX | XXX | XXX |
| P/E/Growth | 0.3x | XXX | XXX | XXX |
| EV/FCF | 52.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSisram Medical's NTM/LTM revenue growth is 19%
Sisram Medical's revenue per employee for the last fiscal year averaged $43K, while opex per employee averaged $21K for the same period.
Over next 12 months, Sisram Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Sisram Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Sisram Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -9% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 34% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $43K | XXX | XXX | XXX | XXX |
| Opex per Employee | $21K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 35% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 49% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sisram Medical acquired XXX companies to date.
Last acquisition by Sisram Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Sisram Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Sisram Medical founded? | Sisram Medical was founded in 2013. |
| Where is Sisram Medical headquartered? | Sisram Medical is headquartered in Hong Kong. |
| How many employees does Sisram Medical have? | As of today, Sisram Medical has 1.1K+ employees. |
| Is Sisram Medical publicy listed? | Yes, Sisram Medical is a public company listed on HKG. |
| What is the stock symbol of Sisram Medical? | Sisram Medical trades under 01696 ticker. |
| When did Sisram Medical go public? | Sisram Medical went public in 2017. |
| Who are competitors of Sisram Medical? | Similar companies to Sisram Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Sisram Medical? | Sisram Medical's current market cap is $267M |
| What is the current revenue of Sisram Medical? | Sisram Medical's last 12-month revenue is $369M. |
| What is the current EBITDA of Sisram Medical? | Sisram Medical's last 12-month EBITDA is $45.8M. |
| What is the current EV/Revenue multiple of Sisram Medical? | Current revenue multiple of Sisram Medical is 0.6x. |
| What is the current EV/EBITDA multiple of Sisram Medical? | Current EBITDA multiple of Sisram Medical is 5.2x. |
| What is the current revenue growth of Sisram Medical? | Sisram Medical revenue growth between 2023 and 2024 was 1%. |
| Is Sisram Medical profitable? | Yes, Sisram Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
